Although the precise influence and relevant mechanism of CCL8 in IPF pathogenesis remain elusive, the utility of this chemokine as a candidate molecule for differential diagnosis and prediction of survival in the IPF context provides insights into the immunoregulatory features of this irreversible disease. This evidence concerns the gene CCL8 and idiopathic pulmonary fibrosis.